TBX3 Regulates Splicing In Vivo: A Novel Molecular Mechanism for Ulnar-Mammary Syndrome

PLoS Genetics

Volumn 10, Issue 3, 2014, Pages

  Kumar, Pavan ^a   Franklin, Sarah ^a,b   Emechebe, Uchenna ^a   Hu, Hao ^a   Moore, Barry ^a   Lehman, Chris ^a   Yandell, Mark ^a   Moon, Anne M ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WEIS CENTER FOR RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; T BOX TRANSCRIPTION FACTOR; TBX3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; RNA PRECURSOR; TBX3 PROTEIN, HUMAN;

ARTICLE; GENE MUTATION; GENETIC DISORDER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PLEIOTROPY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; RNA SPLICING; TRANSCRIPTION REGULATION; ULNAR-MAMMARY SYNDROME; ALTERNATIVE RNA SPLICING; ANIMAL; BIOSYNTHESIS; BREAST DISEASE; GENE EXPRESSION REGULATION; GENETICS; MULTIPLE MALFORMATION SYNDROME; MUTATION; NERVOUS SYSTEM MALFORMATION; PATHOLOGY; PROCEDURES; PROTEIN PROTEIN INTERACTION; PROTEOMICS; ULNA;

ABNORMALITIES, MULTIPLE; ALTERNATIVE SPLICING; ANIMALS; BREAST DISEASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MUTATION; NERVOUS SYSTEM MALFORMATIONS; PROTEIN INTERACTION MAPS; PROTEOMICS; RNA PRECURSORS; RNA, MESSENGER; T-BOX DOMAIN PROTEINS; ULNA;

EID: 84897439827     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004247     Document Type: Article

References (66)

1. Rodriguez M, Aladowicz E, Lanfrancone L, Goding CR, (2008) Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res 68: 7872-7881.
2. Fan W, Huang X, Chen C, Gray J, Huang T, (2004) TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines. Cancer Res 64: 5132-5139.
3. Brummelkamp TR, Kortlever RM, Lingbeek M, Trettel F, MacDonald ME, et al. (2002) TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem 277: 6567-6572.
4. Ito A, Asamoto M, Hokaiwado N, Takahashi S, Shirai T, (2005) Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells. Cancer Lett 219: 105-112.
5. Yarosh W, Barrientos T, Esmailpour T, Lin L, Carpenter PM, et al. (2008) TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res 68: 693-699.
6. Platonova N, Scotti M, Babich P, Bertoli G, Mento E, et al. (2007) TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53. Cell Tissue Res 328: 301-316.
7. Han J, Yuan P, Yang H, Zhang J, Soh BS, et al. (2010) Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 463: 1096-1100.
8. Bakker ML, Boink GJ, Boukens BJ, Verkerk AO, van den Boogaard M, et al. (2012) T-box transcription factor TBX3 reprogrammes mature cardiac myocytes into pacemaker-like cells. Cardiovasc Res 94: 439-449.
9. Frank DU, Carter KL, Thomas KR, Burr RM, Bakker ML, et al. (2012) Lethal arrhythmias in Tbx3-deficient mice reveal extreme dosage sensitivity of cardiac conduction system function and homeostasis. Proc Natl Acad Sci U S A.
10. Bakker ML, Boukens BJ, Mommersteeg MT, Brons JF, Wakker V, et al. (2008) Transcription factor Tbx3 is required for the specification of the atrioventricular conduction system. Circ Res 102: 1340-1349.
11. Meneghini V, Odent S, Platonova N, Egeo A, Merlo GR, (2006) Novel TBX3 mutation data in families with ulnar-mammary syndrome indicate a genotype-phenotype relationship: mutations that do not disrupt the T-domain are associated with less severe limb defects. Eur J Med Genet 49: 151-158.
12. Linden H, Williams R, King J, Blair E, Kini U, (2009) Ulnar Mammary syndrome and TBX3: expanding the phenotype. Am J Med Genet A 149A: 2809-2812.
13. Hasdemir C, Aydin HH, Celik HA, Simsek E, Payzin S, et al. (2010) Transcriptional profiling of septal wall of the right ventricular outflow tract in patients with idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol 33: 159-167.
14. Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, et al. (2010) Genome-wide association study of PR interval. Nat Genet 42: 153-159.
15. Carlson H, Ota S, Campbell CE, Hurlin PJ, (2001) A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome. Hum Mol Genet 10: 2403-2413.
16. Lingbeek ME, Jacobs JJ, van Lohuizen M, (2002) The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J Biol Chem 277: 26120-26127.
17. Carlson H, Ota S, Song Y, Chen Y, Hurlin PJ, (2002) Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene 21: 3827-3835.
18. Boogerd KJ, Wong LY, Christoffels VM, Klarenbeek M, Ruijter JM, et al. (2008) Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43. Cardiovasc Res 78: 485-493.
19. Boogerd CJ, Wong LY, van den Boogaard M, Bakker ML, Tessadori F, et al. (2011) Sox4 mediates Tbx3 transcriptional regulation of the gap junction protein Cx43. Cell Mol Life Sci 68: 3949-3961.
20. Demay F, Bilican B, Rodriguez M, Carreira S, Pontecorvi M, et al. (2007) T-box factors: targeting to chromatin and interaction with the histone H3 N-terminal tail. Pigment Cell Res 20: 279-287.
21. Frank DU, Emechebe U, Thomas KR, Moon AM, (2013) Mouse TBX3 mutants suggest novel molecular mechanisms for Ulnar-mammary syndrome. PLoS One 8: e67841.
22. Hoogaars WM, Barnett P, Rodriguez M, Clout DE, Moorman AF, et al. (2008) TBX3 and its splice variant TBX3+exon 2a are functionally similar. Pigment Cell Melanoma Res 21: 379-387.
23. Singh G, Cooper TA, (2006) Minigene reporter for identification and analysis of cis elements and trans factors affecting pre-mRNA splicing. Biotechniques 41: 177-181.
24. Logan M, Martin JF, Nagy A, Lobe C, Olson EN, et al. (2002) Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33: 77-80.
25. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-882.
26. Coll M, Seidman JG, Muller CW, (2002) Structure of the DNA-bound T-box domain of human TBX3, a transcription factor responsible for ulnar-mammary syndrome. Structure 10: 343-356.
27. Peabody DS, (1993) The RNA binding site of bacteriophage MS2 coat protein. EMBO J 12: 595-600.
28. van den Boogaard M, Wong LY, Tessadori F, Bakker ML, Dreizehnter LK, et al. (2012) Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. J Clin Invest 122: 2519-2530.
29. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, et al. (2006) Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 7: 325.
30. Lapuk A, Marr H, Jakkula L, Pedro H, Bhattacharya S, et al. (2010) Exon-level microarray analyses identify alternative splicing programs in breast cancer. Mol Cancer Res 8: 961-974.
31. Misquitta-Ali CM, Cheng E, O'Hanlon D, Liu N, McGlade CJ, et al. (2011) Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. Mol Cell Biol 31: 138-150.
32. Brugiolo M, Herzel L, Neugebauer KM, (2013) Counting on co-transcriptional splicing. F1000Prime Rep 5: 9.
33. Kulisz A, Simon HG, (2008) An evolutionarily conserved nuclear export signal facilitates cytoplasmic localization of the Tbx5 transcription factor. Mol Cell Biol 28: 1553-1564.
34. Ponicsan SL, Kugel JF, Goodrich JA, (2010) Genomic gems: SINE RNAs regulate mRNA production. Curr Opin Genet Dev 20: 149-155.
35. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T, (2011) Epigenetics in alternative pre-mRNA splicing. Cell 144: 16-26.
36. Hnilicova J, Hozeifi S, Duskova E, Icha J, Tomankova T, et al. (2011) Histone deacetylase activity modulates alternative splicing. PLoS One 6: e16727.
37. David CJ, Chen M, Assanah M, Canoll P, Manley JL, (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463: 364-368.
38. Golan-Gerstl R, Cohen M, Shilo A, Suh SS, Bakacs A, et al. (2011) Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. Cancer Res 71: 4464-4472.
39. Xiao R, Tang P, Yang B, Huang J, Zhou Y, et al. (2012) Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. Mol Cell 45: 656-668.
40. Huelga SC, Vu AQ, Arnold JD, Liang TY, Liu PP, et al. (2012) Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep 1: 167-178.
41. Auboeuf D, Dowhan DH, Kang YK, Larkin K, Lee JW, et al. (2004) Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc Natl Acad Sci U S A 101: 2270-2274.
42. Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, et al. (1999) An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci U S A 96: 6947-6952.
43. Willems P, De Ruyck K, Van den Broecke R, Makar A, Perletti G, et al. (2009) A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure. J Cancer Res Clin Oncol 135: 1159-1168.
44. van Dijk TB, Gillemans N, Stein C, Fanis P, Demmers J, et al. (2010) Friend of Prmt1, a novel chromatin target of protein arginine methyltransferases. Mol Cell Biol 30: 260-272.
45. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, et al. (2009) Recent patterns in gastric cancer: a global overview. Int J Cancer 125: 666-673.
46. Lee CG, (2002) RH70, a bidirectional RNA helicase, co-purifies with U1snRNP. J Biol Chem 277: 39679-39683.
47. Liu ZR, (2002) p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5′ splice site duplex. Mol Cell Biol 22: 5443-5450.
48. Honig A, Auboeuf D, Parker MM, O'Malley BW, Berget SM, (2002) Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Mol Cell Biol 22: 5698-5707.
49. Guil S, Gattoni R, Carrascal M, Abian J, Stevenin J, et al. (2003) Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation. Mol Cell Biol 23: 2927-2941.
50. Govoni KE, Linares GR, Chen ST, Pourteymoor S, Mohan S, (2009) T-box 3 negatively regulates osteoblast differentiation by inhibiting expression of osterix and runx2. J Cell Biochem 106: 482-490.
51. Kurtev V, Margueron R, Kroboth K, Ogris E, Cavailles V, et al. (2004) Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. J Biol Chem 279: 24834-24843.
52. Willis DM, Loewy AP, Charlton-Kachigian N, Shao JS, Ornitz DM, et al. (2002) Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex. J Biol Chem 277: 37280-37291.
53. Dowhan DH, Hong EP, Auboeuf D, Dennis AP, Wilson MM, et al. (2005) Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERalpha and CAPERbeta. Mol Cell 17: 429-439.
54. Fan C, Chen Q, Wang QK, (2009) Functional role of transcriptional factor TBX5 in pre-mRNA splicing and Holt-Oram syndrome via association with SC35. J Biol Chem 284: 25653-25663.
55. Nayler O, Stratling W, Bourquin JP, Stagljar I, Lindemann L, et al. (1998) SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res 26: 3542-3549.
56. Davies RC, Calvio C, Bratt E, Larsson SH, Lamond AI, et al. (1998) WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev 12: 3217-3225.
57. Markus MA, Heinrich B, Raitskin O, Adams DJ, Mangs H, et al. (2006) WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo. Exp Cell Res 312: 3379-3388.
58. Cassiday LA, Maher LJ 3rd, (2002) Having it both ways: transcription factors that bind DNA and RNA. Nucleic Acids Res 30: 4118-4126.
59. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A, (2010) Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39: 373-384.
60. Abdul-Manan N, Williams KR, (1996) hnRNP A1 binds promiscuously to oligoribonucleotides: utilization of random and homo-oligonucleotides to discriminate sequence from base-specific binding. Nucleic Acids Res 24: 4063-4070.
61. Tomonaga T, Levens D, (1995) Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator. J Biol Chem 270: 4875-4881.
62. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, et al. (1996) RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci U S A 93: 7562-7566.
63. Suswam EA, Li YY, Mahtani H, King PH, (2005) Novel DNA-binding properties of the RNA-binding protein TIAR. Nucleic Acids Res 33: 4507-4518.
64. Bamshad M, Le T, Watkins WS, Dixon ME, Kramer BE, et al. (1999) The spectrum of mutations in TBX3: genotype/pheotype relationship in Ulnar-Mammary Syndrome. Am J Hum Genet 64: 1550-1562.
65. Franklin S, Zhang MJ, Chen H, Paulsson AK, Mitchell-Jordan SA, et al. (2011) Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy. Mol Cell Proteomics 10M110 000703.
66. Franklin S, Chen H, Mitchell-Jordan S, Ren S, Wang Y, et al. (2012) Quantitative analysis of the chromatin proteome in disease reveals remodeling principles and identifies high mobility group protein b2 as a regulator of hypertrophic growth. Mol Cell Proteomics 11M111 014258.